Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Francesca Marchignoli
Observed names:
F. Marchignoli,
Marchignoli F
Institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
ORCID:
0000-0002-4862-1274
Observed ORCID:
0000-0002-4862-1274
OpenAlex ID:
A5015977891
Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges
2021
·
Maria Letizia Petroni
, Lucia Brodosi
, et al.
·
Nutrients
·
173
PDF
Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease?
2016
·
Arianna Mazzotti
, Maria Turchese Caletti
, et al.
·
Digestive and Liver Disease
·
54
Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real‐world data analysis
2021
·
Santo Colosimo
, Federico Ravaioli
, et al.
·
Liver International
·
51
PDF
Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?
2019
·
Maria L. Petroni
, Lucia Brodosi
, et al.
·
Nutrients
·
43
PDF
NASH: A glance at the landscape of pharmacological treatment.
2016
·
Lucia Brodosi
, Francesca Marchignoli
, et al.
·
PubMed
·
38
Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity
2024
·
Lucia Brodosi
, Michele Stecchi
, et al.
·
Acta Diabetologica
·
17
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs
2023
·
Maria Letizia Petroni
, Lucia Brodosi
, et al.
·
Nutrients
·
16
Effectiveness of a Model of Care Based on Fibrosis-4 and Liver Stiffness Measurement for the Screening of Patients With Type 2 Diabetes Mellitus at Risk of Advanced Liver Disease: Results From an Italian Prospective Multicenter Study
2025
·
Gian Paolo Caviglia
, Arianna Ferro
, et al.
·
The American Journal of Gastroenterology
·
14
PDF
Evidence-Based Medicine and the Problem of Healthy Volunteers
2017
·
Giulio Marchesini
, Francesca Marchignoli
, et al.
·
Annals of Hepatology
·
14
PDF
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
2023
·
Lucia Brodosi
, Michele Stecchi
, et al.
·
Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity
·
12
Association between Albumin Alterations and Renal Function in Patients with Type 2 Diabetes Mellitus
2024
·
Marta Nugnes
, Maurizio Baldassarre
, et al.
·
International Journal of Molecular Sciences
·
11
Non-Alcoholic Fatty Liver Disease: A 360-degree Overview
2020
·
Brodosi L
, Barbanti F
, et al.
·
Springer eBooks
·
8
Interplay among lipoprotein(a), hepatic and vascular damage in individuals with metabolic dysfunction
2025
·
Serena Pelusi
, Chiara Macchi
, et al.
·
Cardiovascular Diabetology
·
7
PDF
A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes
2022
·
D. Bruttomesso
, C. Irace
, et al.
·
Nutrition Metabolism and Cardiovascular Diseases
·
4
PDF
Effectiveness of the flash glucose monitoring system in preventing severe hypoglycemic episodes and in improving glucose metrics and quality of life in subjects with type 1 diabetes at high risk of acute diabetes complications
2024
·
Alessandra Dei Cas
, Raffaella Aldigeri
, et al.
·
Acta Diabetologica
·
2
Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey
2023
·
Lucia Brodosi
, Michele Stecchi
, et al.
·
Orphanet Journal of Rare Diseases
·
1
WED-293 Effectiveness of on different models of care based on Fibrosis-4 and/or liver stiffness measurement for the screening of patients with type 2 diabetes mellitus at risk of advanced liver disease
2024
·
Gian Paolo Caviglia
, Arianna Ferro
, et al.
·
Journal of Hepatology
Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome
2023
·
Lucia Brodosi
, Michele Stecchi
, et al.
·
Journal of Hepatology
Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interim analysis of an Italian prospective multicentre study
2023
·
Gian Paolo Caviglia
, Angelo Armandi
, et al.
·
Journal of Hepatology
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy
2022
·
Federico Ravaioli
, Maria Letizia Petroni
, et al.
·
Journal of Hepatology
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy
2022
·
F. Ravaioli
, M.L. Petroni
, et al.
·
Digestive and Liver Disease
Considerations when prescribing pharmacotherapy for metabolic associated fatty liver disease
2021
·
Lucia Brodosi
, Francesca Marchignoli
, et al.
·
Expert Opinion on Pharmacotherapy
PDF
Obesity and NAFLD: Same Problem?
2020
·
Lucia Brodosi
, Francesca Alessandra Barbanti
, et al.
·
Springer eBooks
Hepatic effects of new anti-diabetic drugs: real world data from a retrospective study
2019
·
Santo Colosimo
, Lucia Brodosi
, et al.
·
Endocrine Abstracts
Show more works
View as search
Works count:
24
Citation count:
465
H-index:
11
I10-index:
11
Year
Topic
Type